K. Nakayama et al., (+)-[H-3]isradipine and [H-3]glyburide bindings to heart and lung membranes from rats with monocrotaline-induced pulmonary hypertension, JPN J PHARM, 81(2), 1999, pp. 176-184
We examined the binding of a 1,4-dihydropyridine-sensitive Ca2+ channel lig
and, (+)-[H-3]isradipine (PN200-110), and that of an ATP-sensitive K+ (K-AT
P) channel ligand, [H-3]glyburide, to heart, lung and brain membranes isola
ted from Sprague-Dawley rats made pulmonary hypertensive by monocrotaline,
a pyrrolizidine alkaloid. A single subcutaneous injection of monocrotaline
increased right ventricular systolic pressure, a measure of pulmonary arter
ial pressure, and the thickness of the right ventricular free wall in 3 to
4 weeks. The (+)-[H-3]PN200-110 and [H-3]glyburide binding site densities (
B-max) were reduced in hypertrophied right ventricles when normalized per u
nit protein in comparison with those of age-matched control (sham) rats, wh
ereas the values of the dissociation constant (K-d) of both ligands bound t
o the hypertrophied right ventricle were not significantly changed. The [H-
3]PN200-110 binding to the lung membranes of the monocrotaline-induced pulm
onary hypertensive rats was increased, The results indicate that the change
in the binding of 1,4-dihydropyridine Ca2+ and K-ATP channel ligands to he
art membranes may contribute to the pathological alteration of cardiopulmon
ary structure and functions in rats with pulmonary hypertension induced by
monocrotaline.